Literature DB >> 2036749

A computer-based system for controlling plasma opioid concentration according to patient need for analgesia.

H F Hill1, R C Jacobson, B A Coda, A M Mackie.   

Abstract

Microprocessor-controlled infusion pumps, which allow a patient to self-administer bolus doses of an analgesic to relieve pain, are becoming commonplace. While these patient-controlled analgesia (PCA) systems overcome the large interpatient variations in pharmacokinetics, they do not provide steady relief from pain since they rely on delivering a drug in small, incremental doses. To overcome this problem, the authors developed an algorithm and computer-pump system that allows patients to control their own plasma concentration of analgesic. This approach uses individually predetermined pharmacokinetic parameters to provide steady plasma opioid concentrations that can be increased or decreased by the patient in line with the need for more pain relief or fewer side effects. The control software uses a novel, recursive algorithm to compute the pump rates necessary to maintain constant plasma drug (e.g. morphine) concentrations at desired values and to reach a new steady concentration in response to patient requests. This report describes the mathematical approach to the problem of control of plasma opioid concentration, the application of this new drug delivery system to management of persistent pain in cancer patients undergoing bone marrow transplantation, and the magnitude of pharmacokinetic variability with morphine in this patient population. Results are presented from individual patients using this adjustable drug delivery system continuously for up to 2 weeks to control pain from oral mucositis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2036749     DOI: 10.2165/00003088-199120040-00006

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  34 in total

1.  The diposi tion of morphine in surgical patients.

Authors:  B A Berkowitz; S H Ngai; J C Yang; J Hempstead; S Spector
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

2.  Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain.

Authors:  C E Inturrisi; R K Portenoy; M B Max; W A Colburn; K M Foley
Journal:  Clin Pharmacol Ther       Date:  1990-05       Impact factor: 6.875

3.  Prediction of infusion rates: computer study.

Authors:  M J Harrison
Journal:  Br J Anaesth       Date:  1990-03       Impact factor: 9.166

4.  Continuous intravenous infusion and multicompartment accumulation.

Authors:  E Krüger-Thiemer
Journal:  Eur J Pharmacol       Date:  1968-10       Impact factor: 4.432

5.  Self-administered intravenous and intramuscular pethidine. A controlled trial in labour.

Authors:  J O Robinson; M Rosen; J M Evans; S I Revill; H David; G A Rees
Journal:  Anaesthesia       Date:  1980-08       Impact factor: 6.955

6.  Patient-controlled analgesic therapy, Part II: Individual analgesic demand and analgesic plasma concentrations of pethidine in postoperative pain.

Authors:  A Tamsen; P Hartvig; C Fagerlund; B Dahlström
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

7.  Patient-controlled analgesia: a randomized, prospective comparison between two commercially available PCA pumps and conventional analgesic therapy for postoperative pain.

Authors:  Bernice R Hecker; Leonard Albert
Journal:  Pain       Date:  1988-10       Impact factor: 6.961

8.  An evaluation of the accuracy of pharmacokinetic data for the computer assisted infusion of alfentanil.

Authors:  M E Ausems; D R Stanski; C C Hug
Journal:  Br J Anaesth       Date:  1985-12       Impact factor: 9.166

9.  Safety and efficacy of continuous intravenous morphine for severe cancer pain.

Authors:  M L Citron; A Johnston-Early; B E Fossieck; S H Krasnow; R Franklin; S V Spagnolo; M H Cohen
Journal:  Am J Med       Date:  1984-08       Impact factor: 4.965

10.  Chemoradiotherapy toxicity during bone marrow transplantation: time course and variation in pain and nausea.

Authors:  M K Chapko; K L Syrjala; L Schilter; C Cummings; K M Sullivan
Journal:  Bone Marrow Transplant       Date:  1989-03       Impact factor: 5.483

View more
  6 in total

Review 1.  Target-controlled infusion systems: role in anaesthesia and analgesia.

Authors:  M C van den Nieuwenhuyzen; F H Engbers; J Vuyk; A G Burm
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

Review 2.  Pharmacokinetic optimisation of opioid treatment in acute pain therapy.

Authors:  R N Upton; T J Semple; P E Macintyre
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

Review 3.  Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients.

Authors:  Deborah P Saunders; Joel B Epstein; Sharon Elad; Justin Allemano; Paolo Bossi; Marianne D van de Wetering; Nikhil G Rao; Carin Potting; Karis K Cheng; Annette Freidank; Michael T Brennan; Joanne Bowen; Kristopher Dennis; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2013-07-06       Impact factor: 3.603

Review 4.  Patient-controlled analgesia. Pharmacokinetic and therapeutic considerations.

Authors:  H F Hill; L E Mather
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

5.  Evaluation of the accuracy of a pharmacokinetically-based patient-controlled analgesia system.

Authors:  H Hill; A Mackie; B Coda; R Schaffer; R Jacobson; C Benedetti
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 6.  Overview of current development in patient-controlled analgesia.

Authors:  C Lindley
Journal:  Support Care Cancer       Date:  1994-09       Impact factor: 3.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.